The Pandemic Stress Vaccine: A Resource to Enhance the Resilience of Healthcare Workers Facing an Infectious Outbreak
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00962273|
Recruitment Status : Terminated (low participation and retention rates)
First Posted : August 19, 2009
Last Update Posted : August 19, 2010
|Condition or disease||Intervention/treatment||Phase|
|Psychological Stress||Behavioral: Interactive computerized learning resource Behavioral: Didactic computerized learning resource||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||118 participants|
|Intervention Model:||Parallel Assignment|
|Primary Purpose:||Health Services Research|
|Official Title:||The Pandemic Stress Vaccine: Randomized Controlled Trial of an Educational Resource to Enhance the Resilience of Healthcare Workers Facing an Infectious Outbreak|
|Study Start Date :||October 2009|
|Actual Primary Completion Date :||July 2010|
|Actual Study Completion Date :||July 2010|
|Experimental: Pandemic Stress Vaccine - Interactive||
Behavioral: Interactive computerized learning resource
In a series of interactive scenarios, participants can "see" themselves in stressful work situations that could arise during an influenza pandemic and reflect on effective ways to work out personal and interpersonal difficulties.
|Active Comparator: Pandemic Stress Vaccine - Didactic||
Behavioral: Didactic computerized learning resource
In a non-interactive format (i.e., a series of audio presentations with accompanying PowerPoint-type slides) participants are given information on how to handle stressful work situations that could arise during an influenza pandemic.
No Intervention: Wait list
Some participants are assigned to an eight week waiting condition prior to the course commencing.
- Absenteeism [ Time Frame: 32 weeks ]
- Pandemic self-efficacy [ Time Frame: 32 weeks ]
- Interpersonal problems [ Time Frame: 32 weeks ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00962273
|Mount Sinai Hospital|
|Toronto, Ontario, Canada, M5G 1X5|
|Principal Investigator:||William J. Lancee, Ph.D.||Mount Sinai Hospital, New York|
|Principal Investigator:||Robert G. Maunder, M.D.||Mount Sinai Hospital, New York|